Donald Hooker
Stock Analyst at Keybanc
(2.52)
# 2,374
Out of 5,065 analysts
82
Total ratings
55.95%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $6.96 | +1,336.78% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $167.64 | +132.64% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $191.25 | -11.11% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $224.90 | +28.95% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $20.05 | +264.09% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $4.17 | +763.31% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $3.84 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $244.06 | +44.64% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $101.91 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $84.87 | -1.03% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $4.14 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $265.64 | -36.00% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $164.56 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $1.31 | +3,408.77% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $28.17 | - | 1 | Oct 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $591.82 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $6.96
Upside: +1,336.78%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $167.64
Upside: +132.64%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $191.25
Upside: -11.11%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $224.90
Upside: +28.95%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $20.05
Upside: +264.09%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $4.17
Upside: +763.31%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $3.84
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $244.06
Upside: +44.64%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $101.91
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $84.87
Upside: -1.03%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $4.14
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $265.64
Upside: -36.00%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $164.56
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $1.31
Upside: +3,408.77%
Oct 24, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $28.17
Upside: -
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $591.82
Upside: -